Pfizer Inc. (PFE)

Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Pfizer (PFE) and Eli Lilly (LLY). But which of these two stocks is more attractive to value inve...

As geopolitical risks jolt markets, STNE, CNC, CVS and PFE shine with low cash flow valuations and solid earnings outlooks.

In the Large-Cap Pharmaceuticals industry, AbbVie, Novartis, Pfizer, Sanofi and Bayer are worth retaining amid macro pressure and rising innovation.

Traditionally, a large portion of equity returns has come from two factors - reinvested dividends and compounding. We present two income-focused approaches: a fund-based portfolio for hands-off invest...

U.S. firms remain attracted to Ireland's strong business environment built on favorable tax treatment of intellectual property.

PFE's new drug launches and Seagen acquisition are driving revenue gains despite COVID declines and market headwinds.

These four dividend stocks are trading below $50 and have a yield higher than 4%.

Dividend income offers a great way to strengthen your overall financial position. It can potentially make you less dependent on the income you earn from a job, maybe even allowing you to work less or ...

Blue-chip stocks are shares of large, well-established, financially stable companies with a consistent and reliable performance history.

Coincident to the June 5, 2025 annual launch of their Fortune 500, Fortune also partnered with Indiggo to measure Return On Leadership, called the ROL100. Arnold research focused on those 100 using YC...